Association of rs10830963 and rs10830962 SNPs in the melatonin receptor (MTNR1B) gene among Han Chinese women with polycystic ovary syndrome.

The aim of the present study was to determine whether or not the 'melatonin receptor (MTNR1B)' gene polymorphisms are associated with a predisposition for polycystic ovary syndrome (PCOS). The single-nucleotide polymorphisms (SNPs), rs10830963 and rs10830962, in the MTNR1B gene were detected in 526 patients with PCOS and 547 healthy Chinese Han women. The association between MTNR1B gene variants and plasma glucose and insulin levels during the oral glucose tolerance test (OGTT) and hormone levels was investigated. The frequencies of three genotypes and two allelotypes of the SNP, rs10830963, differed significantly between women with PCOS and healthy controls (P < 0.001 and P < 0.001, respectively). The SNP, rs10830963, was significantly associated with higher fasting plasma glucose concentrations (P < 0.001) and increased the area under the curve of plasma glucose levels during the OGTT (P < 0.001), as well as increased homeostasis model assessment of insulin resistance (HOMA-IR; P = 0.027). No significant differences were observed in the genotypes and allele distributions of rs10830962 polymorphisms between the PCOS and the control groups (P = 0.311 and P = 0.178, respectively). There was no significant difference in the clinical and the metabolic characteristics in women with PCOS with different genotypes in the SNP, rs10830962 (all P > 0.005). The present study suggest that the SNP, rs10830963, in the MTNR1B gene is not only associated with susceptibility to PCOS, but also contributes to the PCOS phenotype.

[1]  Min Wang,et al.  Common genetic variation in MTNR1B is associated with serum testosterone, glucose tolerance, and insulin secretion in polycystic ovary syndrome patients. , 2010, Fertility and sterility.

[2]  R. Reiter,et al.  Melatonin and the ovary: physiological and pathophysiological implications. , 2009, Fertility and sterility.

[3]  M. Laakso,et al.  Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response , 2009, Diabetologia.

[4]  L. Groop,et al.  Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene , 2009, Diabetologia.

[5]  L. Groop,et al.  A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals , 2009, Diabetologia.

[6]  N. Stefan,et al.  Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine β-Cell Function , 2008, PloS one.

[7]  E. Peschke,et al.  Involvement of the cGMP pathway in mediating the insulin‐inhibitory effect of melatonin in pancreatic β‐cells , 2008, Journal of pineal research.

[8]  D. Cardinali,et al.  Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways , 2008, Progress in Neurobiology.

[9]  S. Konturek,et al.  Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. , 2007, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[10]  H. Dralle,et al.  Melatonin and type 2 diabetes – a possible link? * , 2007, Journal of pineal research.

[11]  R. Cortvrindt,et al.  Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis. , 2006, Toxicology.

[12]  Karen Chuang,et al.  High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. , 2005, BioTechniques.

[13]  Fred W. Turek,et al.  Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice , 2005, Science.

[14]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[15]  R. Pasquali,et al.  Type 2 diabetes and the polycystic ovary syndrome. , 2004, Minerva ginecologica.

[16]  M. Sheehan.  Polycystic ovarian syndrome: diagnosis and management. , 2004, Clinical medicine & research.

[17]  M. Urbanek,et al.  The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis* , 2003, Journal of Biological Chemistry.

[18]  W. Sadee,et al.  Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves. , 2003, BioTechniques.

[19]  M. Giusti,et al.  Melatonin Participates in the Control of Testosterone Secretion from Rat Testis , 2002, Annals of the New York Academy of Sciences.

[20]  D. Weaver,et al.  Mammalian melatonin receptors: molecular biology and signal transduction , 2002, Cell and Tissue Research.

[21]  C. Tai,et al.  Direct action of melatonin in human granulosa-luteal cells. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  M. Stumvoll,et al.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. , 2000, Diabetes care.

[23]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[24]  S. Franks,et al.  Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. , 1994, The Journal of clinical endocrinology and metabolism.

[25]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[26]  M. Cohen,et al.  Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. , 1992, The Journal of clinical endocrinology and metabolism.

[27]  J. Nestler,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(4):1929–1935 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1045 Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycysti , 2022 .